|
[1]Bazan J F, Bacon K B, Hardiman G, et al.A new class of chemo-kine with a CX3C motif[J].Nature, 1997, 385∶640-644.
|
|
[2]Deng HK, Unutmaz D, KewalRamani VN, et al.Expression cloningof newreceptors used by simian and human immunodeficiency viruses[J].Nature, 1997, 388∶296-300.
|
|
[3]Matloubian M, David A, Engel S, et al.A transmembrane CXCchemokine is a ligand for HIV coreceptor Bonzo[J].Nat Immunol, 2000, 1 (4) ∶298-304.
|
|
[4]Nakayama T, Hieshima K, Izawa D, et al.Cutting edge:profile ofchemokinereceptor expression on human plasma cells accounts fortheir efficient recruitment to target tissues[J].The Journal of Immu-nology, 2003, 170∶1136-1140.
|
|
[5]Morgan AJ, Guillen C, Symon FA, et al.Expression of CXCR6 andits ligand CXCL16 in the lung in health and disease[J].Clincal Ex-perimental Allergy, 2005, 35 (12) ∶1572-1580.
|
|
[6]Agostini C, Cabrelle A, Calabrese F, et al.Role for CXCR6 and ItsLigand CXCL16 in the Pathogenesis of T-Cell Alveolitis in Sarcoid-osis[J].American Journal of Respiratory and Critical Care Medicine, 2005, 172∶1290-1298.
|
|
[7] Lavanchy D, Daniel.Public health measures in the control of viralhepatitis:A World Health Organization perspective for the next mil-lennium[J].Journal of Gastroenterology and Hepatology, 2002, 17 (s4) ∶S452-S459.
|
|
[8] Geissmann F, Cameron TO, Sidobre S, et al.Intravascular ImmuneSurveillance by CXCR6+NKT Cells Patrolling Liver Sinusoids[J].PLoS Biol, 2005, 3 (4) ∶ell3.
|
|
[9]Matsuda JL, Naidenko OV, Gapin L, et al.Tracking the response ofnatural killer T cells to a glycolipid antigen using CD1d tetramers[J].The Journal of Experimental Medicine, 2000, 192 (5) ∶741-754.
|
|
[10]Rossi D, Zlotnik A.The biology of chemokines and their receptors[J].Annual Review of Immunology, 2000, 18∶217-242.
|
|
[11]Luster AD.Chemokines chemotactic cytokines that mediate inflam-mation[J].N Engl J Med, 1998, 338 (7) ∶436-445.
|
|
[12]Heydtmann M, Lalor PF, Immunol J.CXC chemokine ligand 16promotes integrin-mediated adhesion of liver-infiltrating lympho-cytes to cholangiocytes and hepatocytes within the inflamed humanliver[J].Immunol, 2005, 174 (2) ∶1055-1062.
|
|
[13]徐焕宾, 龚燕萍, 储以微, 等.CXCL16抗体可阻断BCG和LPS诱导的小鼠免疫性肝损伤[J].中华微生物学和免疫学杂志, 2005, 25 (2) ∶111-115.
|
|
[14]Tsuji H, Harada A, Mukaida N, et al.Tumor necrosis factor recep-tor p55 is essential for intrahepatic granuloma formation and hepato-cellular apoptosis in a murine model of bacterium induced fulminanthepatitis[J].Infection Immunity, 1997, 65 (5) ∶1892-1898.
|
|
[15]徐焕宾, 龚燕萍, 储以微, 等.CXCL16趋化因子在小鼠免疫性肝损伤中的作用[J].中国免疫学杂志, 2004, 20 (6) ∶369-373.
|
|
[16] Sheikine Y, Bang CS, Nilsson L, et al.Decreased plasma CX-CL16/SR-PSOX concentration is associated with coronary arterydisease[J].Atherosclerosis, 2005, 22[Epub ahead of print].
|
|
[17]Wagsater D, Sheikine Y, Sirsjo A.All-trans retinoic acid regu-lates CXCL16/SR-PSOX expression[J].Int J Mol Med, 2005, 16 (4) ∶661-665.
|
|
[18]Nanki T, Shimaoka T.Pathogenic role of the CXCL16-CXCR6pathway in rheumatoid arthritis[J].Arthritis rheum, 2005, 52 (10) ∶3004-3014.
|
PDF下载 ( 114 KB)
本文二维码
下载:
